0.55Open0.55Pre Close0 Volume93 Open Interest3.00Strike Price0.00Turnover103.24%IV4.67%PremiumDec 20, 2024Expiry Date0.43Intrinsic Value100Multiplier24DDays to Expiry0.12Extrinsic Value100Contract SizeAmericanOptions Type-0.6726Delta0.5361Gamma4.67Leverage Ratio-0.0049Theta-0.0013Rho-3.14Eff Leverage0.0024Vega
Esperion Therapeutics Stock Discussion
someone loaded 520k at close 👀👀👀👀
Esperion Highlights New Exploratory Data from CLEAR Outcomes Trial Highlighting Value of NEXLETOL® (bempedoic acid) in Oral Featured Science Session and Multiple Poster Presentations at AHA Scientific Sessions 2024
Esperion (ESPR) presented new exploratory data from the CLEAR Outcomes trial at the 2024 AHA Scientific Sessions, highlighting significant benefits of NEXLETOL (bempedoic acid).
The analysis showed patients with Peripheral Artery Disease (PAD) tak...
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
No comment yet